Loading...
Please wait, while we are loading the content...
Challenges to optimizing RNA nanostructures for large scale production and controlled therapeutic properties.
| Content Provider | Europe PMC |
|---|---|
| Author | Chandler, Morgan Panigaj, Martin Rolband, Lewis A Afonin, Kirill A |
| Copyright Year | 2020 |
| Abstract | Nucleic acids have been utilized to construct an expansive collection of nanoarchitectures varying in design, physicochemical properties, cellular processing and biomedical applications. However, the broader therapeutic adaptation of nucleic acid nanoassemblies in general, and RNA-based nanoparticles in particular, have faced several challenges in moving towards (pre)clinical settings. For one, the large-batch synthesis of nucleic acids is still under development, with multi-stranded and chemically modified assemblies requiring greater production capacity while maintaining consistent medical-grade outputs. Furthermore, the unknown immunostimulation by these nanomaterials poses additional challenges, necessary to be overcome for optimizing future development of clinically approved RNA nanoparticles. |
| Related Links | https://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC7304434&blobtype=pdf |
| Page Count | 10 |
| ISSN | 17435889 |
| DOI | 10.2217/nnm-2020-0034 |
| PubMed Central reference number | PMC7304434 |
| Issue Number | 13 |
| PubMed reference number | 32452262 |
| Journal | Nanomedicine [Nanomedicine (Lond)] |
| e-ISSN | 17486963 |
| Language | English |
| Publisher | Future Medicine Ltd |
| Publisher Date | 2020-05-26 |
| Publisher Place | London, UK |
| Access Restriction | Open |
| Rights License | © 2020 Future Medicine Ltd |
| Subject Keyword | immune stimulation nanoparticles NANPs RNA nanoparticles RNA nanotechnology self-assembly TNAs |
| Content Type | Text |
| Resource Type | Article |
| Subject | Nanoscience and Nanotechnology Medicine Development Bioengineering Materials Science Biomedical Engineering |